T. Rowe Price Associates’s Achaogen Inc AKAO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-150,229
Closed -$69K 2584
2019
Q1
$69K Buy
150,229
+500
+0.3% +$525 ﹤0.01% 2488
2018
Q4
$184K Sell
149,729
-17,100
-10% -$45.7K ﹤0.01% 2425
2018
Q3
$666K Buy
166,829
+32,479
+24% +$196K ﹤0.01% 2035
2018
Q2
$1.16M Sell
134,350
-875,658
-87% -$10.7M ﹤0.01% 1781
2018
Q1
$13.1M Buy
1,010,008
+62,952
+7% +$714K ﹤0.01% 1288
2017
Q4
$10.2M Buy
947,056
+8,180
+0.9% +$103K ﹤0.01% 1340
2017
Q3
$15M Sell
938,876
-78,043
-8% -$1.49M ﹤0.01% 1267
2017
Q2
$22.1M Sell
1,016,919
-75,858
-7% -$1.73M ﹤0.01% 1137
2017
Q1
$27.6M Buy
+1,092,777
New +$22.4M 0.01% 1029
2015
Q2
Sell
-332,341
Closed -$3.24M 2574
2015
Q1
$3.24M Sell
332,341
-62,259
-16% -$702K ﹤0.01% 1530
2014
Q4
$5.15M Hold
394,600
﹤0.01% 1455
2014
Q3
$3.54M Sell
394,600
-800
-0.2% -$8.19K ﹤0.01% 1501
2014
Q2
$5.52M Buy
395,400
+8,400
+2% +$118K ﹤0.01% 1443
2014
Q1
$5.98M Buy
+387,000
New +$6.69M ﹤0.01% 1404

Other funds holding AKAO

T. Rowe Price Associates's AKAO Position: Q2 2019 in Review

T. Rowe Price Associates sold out of Achaogen Inc (AKAO) in Q2 2019, closing a stake of 150,229 shares — an estimated $69K sold.

T. Rowe Price Associates first reported a position in AKAO in Q1 2014 and held it in 14 quarters. The position peaked at $27.6M in Q1 2017. 8 funds tracked by Wall St. Rank hold AKAO as of Q2 2019.

  • T. Rowe Price Associates reported no remaining Achaogen Inc position as of Q2 2019 after selling out during the quarter.
  • T. Rowe Price Associates sold 150,229 Achaogen Inc shares in Q2 2019, an estimated $69K.
  • T. Rowe Price Associates first reported a position in Achaogen Inc in Q1 2014 and held it in 14 quarters.
  • T. Rowe Price Associates's Achaogen Inc position peaked at $27.6M in Q1 2017.
  • 8 funds tracked by Wall St. Rank held Achaogen Inc as of Q2 2019.

Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.